Zynerba Pharmaceuticals Reports ZYN002 Granted Orphan Drug Designation for Fragile X Syndrome Life Science Investing
Dendritic Cell Vaccine Inhibits Tumor Progression in Preclinical Liver Cancer Model Biotech Investing
DelMar Pharmaceuticals Conference Call – CEO Jeffrey Bacha on Q2 2016 Results Life Science Investing
Retrophin Receives European Orphan Drug Designation for RE-024 for the Treatment of Pantothenate Kinase-Associated Neurodegeneration Biotech Investing
Renova Therapeutics Awarded Additional NIH Funding to Continue Paracrine Gene Therapy Research Biotech Investing
CoLucid Pharmaceuticals Reports Confirmatory Support for Non-vasoconstrictive Mechanism of Action for Lasmiditan Biotech Investing
Pernix Therapeutics Reports Issuance of New Orange Book Patent for Zohydro® ER With BeadTek™ CII Life Science Investing
INC Research Increases Partnership With Society for Clinical Research Sites to Enhance Site Sustainability on a Global Basis Biotech Investing
Minerva Neurosciences Completes Patient Enrollment in Phase IIa Trial of MIN-117 in Major Depressive Disorder Biotech Investing
VBL Therapeutics Launches First Israeli Site as Part of the GLOBE International Pivotal Trial for VB-111 Biotech Investing
